fashion -WSS

fashion

author：comprehensive 2025-09-03 09:19:06 - browse：3

Matts Take Column Illustration — Molly Ferguson for STAT

If you’re a drug company executive, you probably feel like you got up on the wrong side of bed.

On Thursday night, President Biden proposed expanding one of his most popular policies: the Medicare price negotiation process that was put in place as part of the Inflation Reduction Act. “Americans pay more for prescription drugs than anywhere else,” Biden said. “It’s wrong and I’m ending it.”

Obviously, the drug industry is not going to be happy about new price limitations in the U.S., the biggest market for pharmaceuticals. But, even more than that, Biden’s move emphasizes a painful reality: That pharmaceutical companies remain one of the biggest political targets in the country — despite their key role in addressing the Covid-19 pandemic and their development of wildly effective new weight loss drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Health AI: on the border between health care and tech

explore

WSS

Patients, digital health players weigh in on FTC's data privacy plan

What we need to know about Arena Bioworks

Mark Cuban is blaming the wrong people for high drug costs

Congressmen charge Covid hearing ‘could have been an email’

Biogen’s boardroom scandal saddles CEO with first crisis

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

explore

fashion

hotspot

What does generative AI mean for health care? We asked experts

Apple Vision Pro: A first look at health apps on the new VR headset

Medicare details structure of new drug price negotiation program

Juul spent big to court Black leaders to promote its e

At least 13 dead in Texas as scorching temps continue

BMS, looking to build heart drug business, turns to AI for diagnosis

What does generative AI mean for health care? We asked experts

Novo Nordisk touts Wegovy study, but still struggling with supply

Peter Hotez and the public health issue of online harassment

Congressmen charge Covid hearing ‘could have been an email’

focus

Surge in Apellis stock fueled by confidence in safety of its eye drug

Commercial surrogacy can be ethical, despite pope’s claims

Commercial surrogacy can be ethical, despite pope’s claims

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Aspartame and sugar

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

entertainment

focus

explore

entertainment